News

News

Mediclinic and Remgro agree terms buyout

05 Aug 2022


The board of Mediclinic Hospital Group has unanimously backed the £5.04 per share offer made by a consortium including Remgro and shipping company MSC, who offered a premium of 35% to the hospital operator’s shares on May 25, when an initial proposal was made. The transaction is expected to be completed in the first three months of 2023. Remgro, the investment holding company chaired by Johann Rupert, has 44.56% of Mediclinic and is looking for a 50-50 partnership with MSC.

[BACK TO NEWS]